文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

常规收集数据用于随机对照试验:前景、障碍与启示

Routinely collected data for randomized trials: promises, barriers, and implications.
PubMed 文献 · Trials · 2018-01-11

本文概述了常规收集健康数据(RCD)用于随机对照试验(RCT)的前景、挑战与方法学启示。RCD可通过提高可行性、扩展研究议程和提供新设计选项增加价值,但面临监管、伦理、数据及基础设施成本等障碍。未来研究应关注数据质量验证、替代设计对结局评估的影响及报告透明度。

要点

  • RCD用于RCT可降低成本、节省时间与资源,并扩展传统RCT难以回答的研究问题。
  • RCD试验可能增加错分偏倚或稀释效应,但随机化和较大样本量或可抵消。
  • RCD由不参与研究的人员收集,通常对分组盲态,方法学考虑与传统RCT不同。

核心结论

  • RCD在改善RCT实施和降低成本方面有巨大潜力,但需多学科方法应对实际障碍和方法学启示。

研究设计与样本

  • 本文为综述,概述RCD用于RCT的前景、挑战、潜在障碍、方法学启示及研究需求。

主要发现

  • RCD可带来三大益处:通过更好的可行性增加价值(降低费用、时间和资源),扩展研究议程(开展否则难以进行的试验),提供新的设计和数据收集选项(如床旁试验等直接嵌入常规护理的设计)。
  • RCD试验可能因数据由不参与研究的人员收集(对分组盲态)而方法学不同,并可能导致更大的错分偏倚或稀释效应,但随机化和较大样本量或可抵消。
  • 使用RCD可提供外部效度的有价值见解,因为允许进行实用性试验。

关键数值与推荐

  • 原文未报告具体数值标准。

临床怎么用

  • 原文未报告临床实践建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routinely collected health data (RCD) are increasingly used for randomized controlled trials (RCTs). This can provide three major benefits: increasing value through better feasibility (reducing costs, time, and resources), expanding the research agenda (performing trials for research questions otherwise not amenable to trials), and offering novel design and data collection options (e.g., point-of-care trials and other designs directly embedded in routine care). However, numerous hurdles and barriers must be considered pertaining to regulatory, ethical, and data aspects, as well as the costs of setting up the RCD infrastructure. Methodological considerations may be different from those in traditional RCTs: RCD are often collected by individuals not involved in the study and who are therefore blinded to the allocation of trial participants. Another consideration is that RCD trials may lead to greater misclassification biases or dilution effects, although these may be offset by randomization and larger sample sizes. Finally, valuable insights into external validity may be provided when using RCD because it allows pragmatic trials to be performed. METHODS: We provide an overview of the promises, challenges, and potential barriers, methodological implications, and research needs regarding RCD for RCTs. RESULTS: RCD have substantial potential for improving the conduct and reducing the costs of RCTs, but a multidisciplinary approach is essential to address emerging practical barriers and methodological implications. CONCLUSIONS: Future research should be directed toward such issues and specifically focus on data quality validation, alternative research designs and how they affect outcome assessment, and aspects of reporting and transparency.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mc Cord KA, Al-Shahi Salman R, Treweek S, et al. Routinely collected data for randomized trials: promises, barriers, and implications. Trials. 2018. PMID: 29325575. doi:10.1186/s13063-017-2394-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。